Rating: Hold
Corbus Pharmaceuticals Financial Health
Profitability:0.06/10
❌ Corbus Pharmaceuticals has worst Profitability than 100% of the companies on the Biotechnology industry
Net Margin: -1565.79%
❌ Corbus Pharmaceuticals has worst Net Margin than 100% of the companies on the Biotechnology industry
ROE (Return on Equity): -86.05%
❌ Corbus Pharmaceuticals has worst ROE (Return on Equity) than 95.24% of the companies on the Biotechnology industry
ROA (Return on Assets): -29.72%
❌ Corbus Pharmaceuticals has worst ROA (Return on Assets) than 100% of the companies on the Biotechnology industry
Operating Efficiency:0.03/10
❌ Corbus Pharmaceuticals has worst Operating Efficiency than 100% of the companies on the Biotechnology industry
Operating Margin: -1631.84%
❌ Corbus Pharmaceuticals has worst Operating Margin than 100% of the companies on the Biotechnology industry
Liquidity:6.38/10
❌ Corbus Pharmaceuticals has worst Liquidity than 95.24% of the companies on the Biotechnology industry
Quick Ratio: 2.06
❌ Corbus Pharmaceuticals has worst Quick Ratio than 85.71% of the companies on the Biotechnology industry
Operating Cash Flow Ratio: -2.51
❌ Corbus Pharmaceuticals has worst Operating Cash Flow Ratio than 90% of the companies on the Biotechnology industry
Solvency:4.46/10
❌ Corbus Pharmaceuticals has worst Solvency than 85% of the companies on the Biotechnology industry
Debt to Equity Ratio: 0.9
❌ Corbus Pharmaceuticals has worst Debt to Equity Ratio than 85% of the companies on the Biotechnology industry
Interest Coverage Ratio: -2.51
❌ Corbus Pharmaceuticals has worst Interest Coverage Ratio than 90% of the companies on the Biotechnology industry